IDH2 and astrocytoma (excluding glioblastoma): IDH-wt grade 2 astrocytomas (WHO 2016) usually harbor GBM’s molecular alterations, leading to consider them as an immature GBM still missing microvascular proliferation and necrosis (36, 61–63).